Literature DB >> 7531118

Modulation of growth and differentiation of eosinophils from human peripheral blood CD34+ cells by IL5 and other growth factors.

M Shalit1, S Sekhsaria, H L Malech.   

Abstract

Small numbers of CD34+ primitive hematopoietic progenitors are found in normal human peripheral blood. These cells differentiate to myeloid or lymphoid lineage under the influence of different growth factors. We investigated the effects of IL5 and other growth factors on the production of eosinophils from peripheral blood CD34+ cells. CD34+ cells were enriched from normal donors by apheresis and positive selection using an affinity column and plated in agarose with different combinations of cytokines. At 14 days of growth a triple stain technique was used to identify eosinophil, monocyte, and neutrophil colonies. IL5 alone did not support colony growth from CD34+ cells. In contrast, GM-CSF and IL3 alone or together without added IL5 supported the generation of more than 50% pure eosinophil colonies. Addition of IL5 did not change the total number of colonies, but increased the fraction of pure eosinophil colonies to over 70%. Addition of G-CSF reduced the percentage of eosinophil colonies and increased the percentage of neutrophil colonies. Under the best conditions for eosinophil colony growth (IL3+GM-CSF+IL5), the addition of interferon-alpha or bacterial lipopolysaccharide inhibited colony growth by 51 and 58%, respectively. Addition of interferon-gamma, tumor necrosis factor-alpha, or dexamethasone had no effect on eosinophil colonies. Since IL5 alone did not support colony growth from CD34+ cells, we determined when IL5-responsive cells appeared in culture. Cells were grown initially with IL3 + GM-CSF in suspension, washed, and plated in agarose with IL5 alone. Only when progenitors were grown at least 3 days could IL5 serve as the single growth factor supporting pure eosinophil colony growth (47 colonies/10(4) cells plated at Day 3 and 134 colonies/10(4) cells at Day 7). We used neutralizing anti-IL5 antibodies to demonstrate that this late acting IL5 growth effect was specific, and that differentiation of eosinophils in the presence of IL3 + GM-CSF was IL5 independent. Using reverse-transcriptase polymerase chain reaction, the mRNA encoding the eosinophil-specific protein eosinophil peroxidase (EPO) was not detected in Day 0 CD34+ cells, but was demonstrated by Day 3 of culture. We conclude that within 3 days of culture, peripheral blood CD34+ cells can become committed to the eosinophil lineage as demonstrated by responsiveness to IL5 and production of EPO transcripts.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7531118     DOI: 10.1016/0008-8749(95)80008-7

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  12 in total

1.  Cytokine receptor common beta chain as a potential activator of cytokine withdrawal-induced apoptosis.

Authors:  S F Lee; H M Huang; J R Chao; S Lin; H F Yang-Yen; J J Yen
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

2.  Interleukin-4 and RANTES expression in maturing eosinophils derived from human cord blood CD34+ progenitors.

Authors:  J R Velazquez; P Lacy; S Mahmudi-Azer; B Bablitz; C D Milne; J A Denburg; R Moqbel
Journal:  Immunology       Date:  2000-11       Impact factor: 7.397

3.  Eosinophil-specific deletion of IκBα in mice reveals a critical role of NF-κB-induced Bcl-xL for inhibition of apoptosis.

Authors:  Christian Schwartz; Ralf Willebrand; Silke Huber; Rudolf A Rupec; Davina Wu; Richard Locksley; David Voehringer
Journal:  Blood       Date:  2015-04-10       Impact factor: 22.113

4.  Upregulation by glucocorticoids of responses to eosinopoietic cytokines in bone-marrow from normal and allergic mice.

Authors:  M I Gaspar Elsas; E S Maximiano; D Joseph; L Alves; A Topilko; B B Vargaftig; P Xavier Elsas
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

Review 5.  Regulation of allergic airways inflammation by cytokines and glucocorticoids.

Authors:  L Cameron; Q Hamid
Journal:  Curr Allergy Asthma Rep       Date:  2001-03       Impact factor: 4.806

6.  Allergen-induced increases in IL-5 receptor alpha-subunit expression on bone marrow-derived CD34+ cells from asthmatic subjects. A novel marker of progenitor cell commitment towards eosinophilic differentiation.

Authors:  R Sehmi; L J Wood; R Watson; R Foley; Q Hamid; P M O'Byrne; J A Denburg
Journal:  J Clin Invest       Date:  1997-11-15       Impact factor: 14.808

7.  Inflammatory patterns of allergic and nonallergic rhinitis.

Authors:  S E Sobol; P Christodoulopoulos; Q A Hamid
Journal:  Curr Allergy Asthma Rep       Date:  2001-05       Impact factor: 4.919

Review 8.  Eosinophil cytokines, chemokines, and growth factors: emerging roles in immunity.

Authors:  Francis Davoine; Paige Lacy
Journal:  Front Immunol       Date:  2014-11-10       Impact factor: 7.561

9.  The effects of thymic stromal lymphopoietin and IL-3 on human eosinophil-basophil lineage commitment: Relevance to atopic sensitization.

Authors:  Claudia C K Hui; Sina Rusta-Sallehy; Ilan Asher; Delia Heroux; Judah A Denburg
Journal:  Immun Inflamm Dis       Date:  2014-05-09

Review 10.  Emerging Role of Eosinophils in Resolution of Arthritis.

Authors:  Yi Qin; Hui-Zhi Jin; Yu-Jing Li; Zhu Chen
Journal:  Front Immunol       Date:  2021-10-18       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.